Human glycosylated haemoglobin A 1C is a stable minor variant formed in vivo by post-translational modification of the main form of haemoglobin by glucose. Crystals of oxyHbA 1C were obtained using the hanging-drop vapour-diffusion method and PEG as precipitant. The diffraction pattern of the crystal extends to a resolution of 2.3 Å at 120 K. The crystals belong to space group C2, with unitcell parameters a = 237.98, b = 59.27, c = 137.02 Å , = 90.00, = 125.40, = 90.00 . The presence of two and a half molecules per asymmetric unit gives a crystal volume per protein weight (V M ) of 9.70 Å 3 Da À1 and a solvent content of 49%.
Introduction
The nonenzymatic glycosylation reaction is a common posttranslational modification which occurs with a variety of proteins, such as collagen, albumin, tubulin and many others (Robins & Bailey, 1972; Guthrow et al., 1979; Mikšík & Deyl, 1997; Williams et al., 1982) . Glucose reacts in a nonenzymatic way withand/or "-amino groups of proteins in vitro and in vivo (Mikšík & Deyl, 1997; Shapiro et al., 1980) . An in vivo occurrence of this reaction was confirmed with the discovery of a naturally existing minor human haemoglobin component, HbA 1C , which is the product of a slow condensation reaction resulting from the aldehyde properties of the glucose molecule (Cohen & Wu, 1994) .
Measurement of HbA 1C in blood has been used for more than 20 y for long-term monitoring of the glycaemic status of patients with both type 1 and type 2 diabetes mellitus (Bunn et al., 1975; Baynes et al., 1984; Oltman et al., 1997) . However, glycosylated Hb per se is an unlikely factor in the pathophysiology of diabetic complications (Zhang et al., 2001) .
Haemoglobin A 1C (HbA 1C ) is a stable minor haemoglobin (Hb) variant formed in vivo by post-translational modification of the main HbA 1 form with glucose. Originally, HbA 1C was identified by cationexchange column chromatography as it has distinct charge differences compared with unmodified HbA 1 and other glycohaemoglobins (Bunn et al., 1979) . Early structural studies of glycohaemoglobins, in particular the HbA 1C fraction, demonstrated that glycosylation occurs mainly at the N-terminal amino-acid residues of the haemoglobin -chains (Bunn et al., 1975) . This reaction has been shown to proceed through the initial reversible condensation of glucose and the -amino groups of Val1 residues of the -chains, followed by the formation of a Schiff base or aldimine which then undergoes a nearly irreversible intermolecular Amadori rearrangement (Bunn et al., 1975; Koenig et al., 1977) to a more stable ketoamine form, amino-1-deoxyfructose.
However, in view of the numerous glycosylation sites of haemoglobin, the issue of potential double glycosylation of both -chains, the presence of glycosylated N-terminal valines in the -chains or an additional glycosylation at any lysine of either theor -chains remains an open question (Peterson et al., 1998) . These glycosylated haemoglobins are characterized by similar physical chemical properties and as a result can coelute with HbA 1C .
In addition to the importance of the development and standardization of HbA 1C quantification methods used in clinical assays, it should be noted that this minor haemoglobin form is an interesting object in itself. For example, it has been shown that the carbohydrate modification of haemoglobin is the reason for the steric barrier increase to the interaction of allosteric effectors with HbA 1C (DeRosa et al., 1998; Syakhovich et al., 2004) and affects its transport function through redistribution of long-lived and short-lived components in photo-dissociated oxygen recombination kinetics (Okenchi et al., 2001; Bokut et al., 2003) .
Thus, the study of the glycosylated haemoglobin structure will play an important role in investigations of the pathogenesis of diabetes mellitus and its complications. In the present study, the crystallization and preliminary crystallographic analysis of the haemoglobin HbA 1C chromatographic fraction are reported.
Materials and methods

Purification of oxyhaemoglobin A 1C
Fresh blood samples from healthy adult volunteers were collected in heparin-containing tubes. After centrifugation of the samples at 3000g for 7 min to remove plasma, erythrocytes were washed four times with isotonic NaCl solution (155 mM) and centrifuged at 3000g for 7 min. Haemolysate was prepared by incubating the cells with cold water. To remove cell debris, the mixture was centrifuged at 277 K for 45 min at 14 000g.
After lysis of erythrocytes, haemoglobin HbA 1 was isolated and purified to homogeneity by ion-exchange chromatography on a DEAE Sepharose column (5 Â 30 cm; Huisman & Dozy, 1962 , 1965 . Prior to chromatography, the haemoglobin solution was dialyzed against 0.05 M Tris-HCl buffer pH 8.6. The clear red solution was applied onto a DEAE Sepharose column pre-equilibrated with 0.05 M Tris-HCl buffer pH 8.5. The protein was then eluted with a reverse linear pH gradient of 0.05 M Tris-HCl buffer at pH values ranging from 8.5 to 7.0. This method allows isolation of the homogeneous adult haemoglobin (HbA 1 and minor HbA 2 forms) as well as efficient elimination of organic phosphates from the haemoglobin preparations (Huisman & Dozy, 1965) . All chromatographic steps were performed on a BioLogic work station (BioRad, USA).
Fractions of purified HbA 1 were combined, concentrated and nonenzymatically glycosylated in vitro at 277 K for 72 h by incubating 5 mM HbA 1 in 200 mM potassium phosphate buffer pH 7.4 (Watkins et al., 1987) containing glucose in a ratio of 1:100 (haemoglobin: glucose).
HbA 1C was isolated and purified to homogeneity by cationexchange chromatography on a CM Sepharose Fast Flow column. The column (2.6 Â 30 cm) was pre-equilibrated with 50 mM potassium phosphate buffer pH 6.6. Prior to loading, haemoglobin was dialyzed twice against 300 volumes of 50 mM potassium phosphate buffer pH 6.6 for 24 h. HbA 1C was eluted with a linear gradient of NaCl (0.01-0.05 M) in 50 mM potassium phosphate buffer pH 6.6 with additional elution with 50 mM potassium phosphate buffer pH 6.6 containing 0.05 M NaCl. Subsequent washing of the column with a linear gradient of NaCl (0.05-0.1 M) in 50 mM potassium phosphate buffer pH 6.6 resulted in the elution of non-modified oxyhaemoglobin A 1 and methaemoglobin (MetHb).
The fractions containing HbA 1C were combined, concentrated and reloaded onto a CM Sepharose Fast Flow column. Prior to loading, the labile glycohaemoglobin fraction (pre-HbA 1C ) was eliminated by incubation of the HbA 1C preparation at 310 K for 45 min with 20 volumes of sodium acetate buffer pH 5.5 containing 0.1 mM NaCl (Antonini & Brunori, 1971 ).
The final HbA 1C preparation was checked by electrophoresis. The haemoglobin samples (4 ml) were analyzed on agarose gel (Hydragel Hb Glyco 'Sebia', France), which separates major haemoglobin A 1 and its glycosylated species. The migration was performed for 30 min at 50 V, stained with a specific dye from the Hydragel Hb Glyco Kit and washed with distilled water. The gel shows that only glycosylated haemoglobin species are present in the purified sample.
The resulting preparations were concentrated by centrifugation using Amicon YM-05 ultrafiltration membranes (USA).
Mass-spectrometric analysis of haemoglobin prior and after crystallization
Mass-spectrometric studies (Fig. 1) were performed in the positiveion mode using a commercially available Micromass LC-T electrospray ionization orthogonal time-of-flight mass spectrometer. Calibration was performed using protonated horse heart myoglobin (Sigma).
Crystals were washed three times in drops of 8 M ammonium acetate and dissolved in 10 ml 50 mM ammonium acetate.
Samples were diluted in a 1:1(v:v) water-acetonitrile mixture acidified with 1%(v/v) formic acid to achieve a concentration of 5 pmol ml À1 .
Sample solutions were introduced into the mass-spectrometer source with a syringe pump (Harvard Type 55 1111, Harvard Apparatus, South Natick, MA, USA) with a flow rate of 5 ml min À1 . The sample-cone voltage (V c ) was typically set to 40-45 V.
Spectroscopic determinations and data analysis
At all isolation and purification stages, the concentrations of HbA 1 O 2 and HbA 1C O 2 were determined on a Shimadzu 2501 (Shimadzu Corp., Japan) UV-Vis spectrophotometer using a molar extinction coefficient of 13.8 mM À1 cm À1 at 541 nm (Antonini & Brunori, 1971 ).
Crystallization
Crystallization was carried out using the hanging-drop vapourdiffusion method at 277 K. Prior to crystallization, the oxyhaemoglobin was concentrated to 20 mg ml À1 in buffer containing 50 mM sodium/potassium phosphate pH 6.70. Prior to drop preparation, oxygen was bubbled through the haemoglobin and reservoir solutions. The oxygenation state of haemoglobin and the absence of Mass-spectrometric analysis of dissolved crystals. Four species were observed: A, 15 126 Da, assigned to the -subunit; B, 15 868 Da, assigned to the -subunit; C, 16 028 Da, assigned to the -subunit modified by one glucose; D, 15 936 Da, assigned to the -subunit modified by one glucose with one oxygenated haem. methaemoglobin were controlled by spectrophotometric parameters (Soret band position, ratio D 575 /D 540 , absorption at 630 nm).
The standard oxyhaemoglobin crystallization method (Perutz, 1968 ) was adapted to the hanging-drop method. Several crystallization conditions were identified using PEG as a precipitant. These conditions were optimized by variation of pH, PEG molecular weight and protein concentration. The best quality crystals were obtained using a reservoir solution containing 100 mM sodium/potassium phosphate pH 6.70 and 25% PEG 4000. To prevent haemoglobin oxidation by heavy-metal ions, all reservoir solutions additionally contained 2 mM EDTA. 4 ml hanging drops containing 2 ml protein solution mixed with 2 ml reservoir solution were set up on siliconized cover slips over 0.5 ml reservoir solutions in 24-well plates. Single needle-like crystals with maximum dimensions of 0.1 Â 0.2 Â 2 mm (Fig. 2 ) grew at 277 K in approximately 2 d.
Data collection and analysis
Crystals were soaked in a cryoprotectant solution [reservoir solution with 25%(v/v) glycerol] for 10 s, picked up in a loop and then flash-cooled to 120 K in a stream of nitrogen gas prior to data collection.
Data sets were collected at the European Synchrotron Radiation Facility at the Swiss Light Source, Villigen, Switzerland.
Diffraction data were processed using the programs DENZO and SCALEPACK (Otwinowski & Minor, 1997;  see Table 1 and Fig. 3 ).
Results
Gel analysis on the final fraction shows that only glycosylated haemoglobin tetramers are present in the purified sample.
Mass-spectrometric analysis of the final HbA 1C tetramers before and after crystallization showed the presence of modified haemoglobin (Fig. 1) . In both cases, the mass spectrum shows the presence of glycosylated and non-glycolsylatedand -subunits, indicating the presence of tetramers containing one or two glycosylatedand/or -subunits.
The crystals belong to space group C2, with unit-cell parameters a = 237.98, b = 59.27, c = 137.02 Å , = 90.00, = 125.40, = 90.00 . The resolution limit is 2.3 Å .
Determination of the structure is being performed using molecular-replacement methods. In a first analysis, the solution shows 2.5 tetramers in the asymmetric unit. Preliminary analysis shows large conformational changes in the quaternary structure compared with the various models used. The process of rebuilding is under way.
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Figure 2
Crystal of human glycosylated haemoglobin. 
Figure 3
X-ray diffraction image of glycosylated haemoglobin. The inset shows diffraction spots at the resolution limit used in data processing.
